Naproxen
NDC 11534-211, Naproxen, tablet, delayed release, from Sunrise Pharmaceutical, Inc..
- Product NDC
- 11534-211
- Status
- Listed
- Labeler
- Sunrise Pharmaceutical, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091432
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11534-211 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN375 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11534-211-01 | 11534021101 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (11534-211-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f2fb222a-b854-4e6f-9027-2e08aed24185
Use it
Look up 11534-211 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11534-211 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11534-211. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.